Tianjin Pharmaceutical (600488.SH): Histidine chemical raw materials approved for marketing

Zhitong Finance App News, Jinyao Pharmaceutical (600488.SH) issued an announcement. Recently, the company received the “Notice of Approval of Application for the Marketing of Chemical Ingredients” for histidine approved and issued by the State Drug Administration. Histidine is an alpha-amino acid. In the field of nutrition, histidine is considered an essential amino acid for humans, mainly for children. Adding a small amount of histidine to the diet of patients with chronic uremia increases the rate at which the amino acid binds to hemoglobin and reduces nephrogenic anemia, so histidine is also an essential amino acid for uremia patients. Histidine is an important component in amino acid infusions and comprehensive amino acid preparations. It is commonly used to treat kidney failure, anemia, liver disease, etc. Currently, the dosage forms marketed at home and abroad are mainly injections, granules, and oral solutions.

The company previously had 25 types of domestic amino acid raw materials. This time, the histidine API obtained the “Notice of Approval of the Application for the Marketing of Chemical Ingredients”, indicating that the API meets the requirements of the relevant regulations of national drug registration and can be sold to the domestic market, which will further enrich the company's product structure, give full play to the advantages of integrated API formulations, and help expand the company's business field.